Spring Valley Acquisition Corp. Completes $230 Million Initial Public Offering

Spring Valley Acquisition Corp. Completes $230 Million Initial Public Offering

DALLAS–(BUSINESS WIRE)–
Spring Valley Acquisition Corp. (the “Company”), a blank check company sponsored by Pearl Energy Investment II, L.P. (“Pearl”) and formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the closing of its initial public offering of 23,000,000 units at a price of $10.00 per unit, which includes the exercise in full by the underwriters of their overallotment option to purchase an additional 3,000,000 units. Total gross proceeds from the offering were $230 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

While the Company may pursue an initial business combination target in any business or industry, the Company is targeting companies focusing on sustainability, including clean energy and storage, smart grid/efficiency, environmental services and recycling, mobility, water and wastewater management, advanced materials and technology enabled services. The Company’s sponsor is an affiliate of Pearl, an investment firm that focuses on partnering with best-in-class management teams to invest in the North American energy industry, typically targeting opportunities requiring $25 million to $100 million of equity capital.

The units began trading on The Nasdaq Capital Market (“Nasdaq“) under the ticker symbol “SVSVU” on November 24, 2020. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq under the symbols “SV” and “SVSVW,” respectively.

Cowen and Company, LLC and Wells Fargo Securities, LLC acted as joint book running managers and Drexel Hamilton, LLC and Siebert Williams Shank and Co., LLC acted as co-managers for the offering.

The offering was made only by means of a prospectus. A copy of the final prospectus related to the offering may be obtained from: Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, telephone: (833) 297-2926 or by email at [email protected], or Wells Fargo Securities, Attn: Equity Syndicate Department, 500 West 33rd Street, New York, New York 10001, telephone: (800) 326-5897 or email a request to [email protected].

A registration statement relating to the offering has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (the “SEC”) on November 23, 2020. Copies of the registration statement, as amended, can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and any prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Spring Valley Acquisition Corp.

www.sv-ac.com

Robert Kaplan

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Logo
Logo

Horizons ETFs Announces Changes to Name & Index for HXX

Canada NewsWire

TORONTO, Nov. 27, 2020 /CNW/ – Horizons ETFs Management (Canada) Inc. (“Horizons ETFs” or the “Manager“) is pleased to announce that the underlying index of the Horizons EURO STOXX 50® Index ETF (the “ETF“) will change from the EURO STOXX 50® Future Rolls Index (Total Return) to the Solactive Europe 50 Rolling Futures Index (Total Return) and the name of the ETF will change to the Horizons Europe 50 Index ETF.

Currently, the ETF seeks to replicate, to the extent possible, the performance of the EURO STOXX 50® Futures Roll Index (Total Return), net of expenses. The ETF will change its underlying index from the current Index to the Solactive Europe 50 Rolling Futures Index (Total Return) (the “New Index“).


Current ETF Name


New ETF Name


Index Until
December 1


Index On and After
December 1

Horizons EURO STOXX
50® Index ETF

Horizons Europe 50 Index
ETF

EURO STOXX 50®
Future Rolls Index
(Total Return)

Solactive Europe 50
Rolling Futures Index
(Total Return)

The Solactive Europe 50 Rolling Futures Index (Total Return) is designed to measure the performance of 50 of the largest companies that are sector leaders in the Eurozone. The New Index is licensed from Solactive AG (the “Index Provider“), and is calculated and distributed by the Index Provider. The New Index tracks the performance of a EUREX active month EUROSTOXX50 futures contract, and rolls the exposure over four days from the active contract into the next active contract (the “Roll Period“). The full index methodology is available at www.Solactive.com.

In all other respects, the fundamental investment objectives, investment strategies, restrictions, risk factors and fee structure (including the management fee and forward document expenses payable by the ETF) remain the same. The change in index will not affect or change the investment sectors, management fee, distribution policy or risk assessment relating to the ETF. The ETF will continue to trade on the Toronto Stock Exchange (the “TSX“) under the ticker symbol HXX.

The Manager anticipates that the underlying index change will take effect at the open of business on December 1, 2020, with the name change of the ETF following on that date or as soon as practicable thereafter.

About Solactive (
www.Solactive.com
)

Solactive is a leading provider of indexing, benchmarking, and calculation solutions for the global investment and trading community. As at April 2020, Solactive served approximately 450 clients across the world, with approximately US$200 billion invested in products linked to our indices. Solactive is registered with ESMA as a benchmark administrator and is supervised by the BaFin.

About Horizons ETFs Management (Canada) Inc. (
www.HorizonsETFs.com
)

Horizons ETFs Management (Canada) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $15.8 billion of assets under management and 93 ETFs listed on major Canadian stock exchanges, as at October 31, 2020.

Commissions, management fees and expenses all may be associated with an investment in exchange traded products (the “Horizons Exchange Traded Products”) managed by Horizons ETFs Management (Canada) Inc. The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.

SOURCE Horizons ETFs Management (Canada) Inc.

Reliq Health Technologies, Inc. Issues Correction to Shareholder Webinar Date

HAMILTON, Ontario, Nov. 27, 2020 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, wishes to inform shareholders that it will be hosting a webinar on December 1, 2020 at 6:00am PST / 9:00am EST to review the Company’s quarterly financial statements for Q1 Fiscal Year 2021 (July 1 – September 30, 2020), and provide a corporate update. Please note that an earlier release incorrectly specified the date for the webinar as December 2, 2020.

Webinar Login Information
:

Date:  Tuesday, December 1, 2020
Time: 6:00am PST / 9:00am EST
URL: https://bit.ly/37eU7rA

For those who are not able to attend the webinar, a recording will be available on the Company’s website (www.reliqhealth.com) immediately following the session.

About Reliq Health

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home and in the community setting, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information please contact:
Investor Relations at [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

 



Vision Marine Technologies Announces Closing of Initial Public Offering of Common Shares and Full Exercise of Underwriter’s Over-Allotment Option

Montreal, Quebec, Nov. 27, 2020 (GLOBE NEWSWIRE) — via NewMediaWire— Vision Marine Technologies Inc. (Nasdaq: VMAR), the leading provider of electric technology in the design and manufacture of the first fully electric powertrain outboard motor (E-Motion) and electric power boats, today announced the closing of its initial public offering of 2,760,000 common shares at a price of US$10.00 per share, which includes 360,000 shares sold upon full exercise of the underwriter’s option to purchase additional common shares. The gross proceeds from the offering, including the exercise of the over-allotment option, were US$27,600,000, before deducting underwriting discounts, commissions and offering expenses. 

ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering.  

Vision intends to use the net proceeds from the offering for sales and marketing, build-up of inventory for order fulfillment, research and development, development of rental operations, and general working capital.

A registration statement on Form F-1 (File No. 333-239777) relating to the shares was filed with the Securities and Exchange Commission (“SEC”) and became effective on November 23, 2020, and a related registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended.  The offering was made only by means of a prospectus. Copies of the final prospectus may be obtained from ThinkEquity, a division of Fordham Financial Management, Inc., 17 State Street, 22nd Floor, New York, New York 10004, by telephone at (877) 436-3673, or by email at [email protected].  The final prospectus is available on the SEC’s website located at http://www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.


About Vision Marine Technologies

Vision Marine Technologies Inc., (NASDAQ: VMAR) strives to change and be a contributing factor in fighting the problem of waterway pollution by disrupting the boating industry with electric power, contributing to zero pollution, zero emission, wave less water, and a noiseless environment.

Our flagship outboard powertrain (E-Motion) is the first fully electric outboard powertrain system that combines an advanced battery pack, inverter, and high efficiency motor with proprietary union assembly between the transmission and the electric motor design and extensive control software. Our E-Motion technologies used in this powertrain system are designed to improve the efficiency of the outboard powertrain and, as a result, increase range and performance.

Vision continues to design, innovate, manufacture, and sell our handcrafted, high performance, environmentally friendly, electric recreational powerboats to recreational customers.

The design and technology applied to our boats results in far greater and enhanced performance, higher speeds, and longer range. Simply stated, a smoother ride than a traditional ICE motorboat.  

 Forward-Looking Statements

The statements contained in this press release that are not historical facts are forward-looking statements. For example, when Vision discusses the expected use of proceeds, it is using forward-looking statements. These forward-looking statements are based on Vision’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are different to predict or quantify. Actual results may differ materially from these expectations due to changes in global, regional, or local economic, business, competitive, market, regulatory and other factors, many of which are beyond Vision’s control. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in Vision’s filings with the SEC, including its registration statement on Form F-1, as amended from time to time, under the caption “Risk Factors.” Any forward-looking statement in this press release speaks only as of the date of this release. Vision undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

For further information, please contact:

Bruce Nurse, Investor Relations

(800) 871-4274

[email protected]



Linda and Lou Van de Vorst Receive MADD Canada Excellence In Public Policy Award

SASKATOON, Saskatchewan, Nov. 27, 2020 (GLOBE NEWSWIRE) — MADD Canada’s first Robert M. Solomon Award for Excellence in Public Policy is being presented to Linda and Lou Van de Vorst for their work to reduce impaired driving and strengthen provincial impaired driving laws. 

“The Robert M. Solomon Award was established to recognize a volunteer or group that has made an outstanding contribution to the advancement of MADD Canada’s public policy initiatives to strengthen impaired driving laws,” said MADD Canada Chief Executive Officer Andrew Murie. “With their passionate efforts to change impaired driving laws in Saskatchewan, Linda and Lou truly embody the spirit of this award and we are honoured to name them as its first recipients.”

In January 2016, Linda and Lou’s son Jordan, daughter-in-law Chanda and grandchildren, Kamryn and Migure, were tragically killed in an impaired driving crash.

Since that time, Linda and Lou have worked to strengthen impaired driving legislation to reduce crash deaths and injuries. They have met with the Provincial Government to advocate for changes, including immediate roadside prohibitions, increased fines and vehicle impoundments. Their efforts contributed to the implementation of new legislation that helped reduce impaired driving fatalities and injuries. In 2019, 21 people were killed and 332 people were injured in impairment-related crashes in Saskatchewan. That is down significantly from the annual average of 54 deaths and 595 injuries between 2009 and 2018.

The award was presented to the Van de Vorsts today by The Honourable Joe Hargrave, Minister of Highways. In his previous post as Minister responsible for Saskatchewan Government Insurance, Minister Hargrave worked with Linda and Lou on numerous events and initiatives around Saskatchewan’s impaired driving laws, as well as powerful public awareness efforts to prevent impaired driving.

“I am truly honoured to present this award to Linda and Lou,” said Minister Hargrave.  “I can’t thank them enough for all they have done to reduce impaired driving in Saskatchewan. The Van de Vorsts, along with a number of families impacted by impaired driving, have worked alongside government to truly make a difference and for that I am so very thankful.”

Linda and Lou heralded the work of victims and survivors, volunteers, partners in law enforcement and government, and the general public in the ongoing effort to reduce impaired driving, noting “it takes everyone working together to make Saskatchewan roadways safer”.

About the Robert M. Solomon Award

Established in 2019, this award is named in honour of Robert M. Solomon, who is a Distinguished University Professor in the Faculty of Law at the University of Western Ontario. He also served as MADD Canada’s National Director of Legal Policy for 21 years, guiding the organization’s extensive public policy work on the national and provincial/territorial levels. An internationally recognized expert in the anti-impaired driving field, Professor Solomon has worked tirelessly to assess best practices in impaired driving policy and to advocate for legislative amendments that would save lives and prevent injuries. He has made numerous presentations and submissions to tribunals, government agencies and legislative committees on matters related to impaired driving laws and policies, and his work has been regularly published in peer-reviewed journals.



For more information: 
Andrew Murie, MADD Canada Chief Executive Officer, 416-720-7642 or [email protected] 
Tracy Crawford, MADD Canada Western Regional Manager, 1-877-676-6233, [email protected]

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

CHICAGO–(BUSINESS WIRE)–
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on November 25, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 18,000 shares, and restricted stock units for an aggregate of 70,200 shares, of its common stock to 11 new employee(s) under Xeris’ Inducement Equity Plan.

Xeris’ Inducement Equity Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Xeris or one of its subsidiaries as an inducement material to such individual’s entering into employment with Xeris or one of its subsidiaries, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The non-qualified stock options will vest over a period of four years, either 25% on the first anniversary of the grant with the remaining 75% vesting in thirty-six equal monthly installments thereafter, or 36% on 18 months after the grant date with the remaining 64% vesting in ten equal quarterly installments thereafter, and are subject to the employees’ continued employment with Xeris or one of its subsidiaries. The restricted stock units will vest over a period of four years in equal annual installments, and are subject to the employees’ continued employment with Xeris or one of its subsidiaries. All equity awards are subject to the terms and conditions of Xeris’ Inducement Equity Plan and forms of award agreements covering the grants.

About Xeris Pharmaceuticals, Inc.

Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world.

With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first commercial product, Gvoke®. Its proprietary XeriSol™ and XeriJect™ formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xeris’ technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system.

Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on Twitter, LinkedIn or Instagram.

Investor Contact

Allison Wey

Senior Vice President, Investor Relations and Corporate Communications

[email protected]

312-736-1237

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Medical Supplies Health Diabetes Other Health General Health Pharmaceutical

MEDIA:

Moderna to Present at Upcoming Investor Conferences in December 2020

Moderna to Present at Upcoming Investor Conferences in December 2020

CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced its participation in the following upcoming virtual investor conferences:

  • Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 12:30 p.m. ET.
  • Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020 at 9:00 a.m. ET.
  • Nasdaq 43rd Virtual Investor Conference on Friday, December 4, 2020 at 12:00 p.m. ET.
  • BMO 2020 Growth & ESG Conference on Wednesday, December 9, 2020 at 8:00 a.m. ET.

A live webcast of each presentation will be available under “Events and Presentations” in the Investors section of the Moderna website at https://investors.modernatx.com/. A replay of each webcast will be archived on Moderna’s website for 30 days following the presentation.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense; the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) and the Coalition for Epidemic Preparedness Innovations (CEPI). Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.

Investors:

Lavina Talukdar

Senior Vice President & Head of Investor Relations

617-209-5834

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Science Biotechnology Research Pharmaceutical Oncology Health Infectious Diseases Genetics

MEDIA:

Logo
Logo

LEADING ROSEN LAW FIRM Reminds Royal Caribbean Cruises Ltd. Investors of Important December 7 Deadline in Securities Class Action – RCL

NEW YORK, Nov. 27, 2020 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Royal Caribbean Cruises Ltd. (NYSE: RCL) between February 4, 2020 and March 17, 2020, inclusive (the “Class Period”) of the important December 7, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Royal Caribbean investors under the federal securities laws.

To join the Royal Caribbean class action, go to http://www.rosenlegal.com/cases-register-1966.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose material adverse facts about Royal Caribbean’s decrease in bookings outside China and its faulty policies and procedures to prevent the circulation of COVID-19 on its cruise ships. Specifically, regarding global bookings, Royal Caribbean: (1) misled investors to believe that any issue related to COVID-19 was relatively insignificant; (2) falsely assured investors that bookings outside China were strong with no signs of a slowdown; and (3) failed to disclose that the Company was experiencing material declines in bookings globally due to customer concerns over COVID-19. Additionally, regarding safety procedures, Royal Caribbean: (1) falsely assured investors that it implemented rigorous safety protocols; (2) stated such protocols were expected to ultimately contain the spread of COVID-19; and (3) failed to disclose that its ships were following grossly inadequate protocols that would foster the spread of COVID-19 and pose a substantial risk to passengers and crews. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 7, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1966.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        [email protected]
        [email protected]
        www.rosenlegal.com



Castor Maritime Inc. Announces Results of its 2020 Annual General Meeting of Shareholders

LIMASSOL, Cyprus, Nov. 27, 2020 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor” or the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, announces today that the Company’s Annual Meeting of Shareholders (the “Meeting”) was duly held on November 25, 2020 at 9:00 a.m., local time, at the offices of Seward & Kissel LLP, One Battery Park Plaza, New York, New York 10004.

At the Meeting, each of the following proposals were approved and adopted:

  1. The re-election of Mr. Petros Panagiotidis to serve as Class C Director until the 2023 Annual Meeting of Shareholders;
  2. The appointment of Deloitte Certified Public Accountants S.A. as the Company’s independent auditors for the fiscal year of 2020; and
  3. The granting of discretionary authority to the Company’s board of directors (the “Board”) to effect one or more reverse stock splits of the Company’s issued common shares, at a ratio of not less than one-for-two and not more than one-for-75 and in the aggregate at a ratio of not more than one-for-75, inclusive, with the exact ratio to be set at a whole number within this range to be determined by the Board, or any duly constituted committee thereof, and to authorize the Board to implement any such reverse stock split by filing any such amendment to the Company’s Articles of Incorporation with the Registrar of Corporations of the Republic of the Marshall Islands at any time following such approval.

The Company continues to monitor the closing bid price of its common shares during the compliance period and intends to take all necessary steps to regain compliance with the Nasdaq Capital Market (“Nasdaq”) $1.00 minimum bid price per share requirement and to maintain its Nasdaq listing, including by effecting a reverse stock split consolidating the Company’s issued and outstanding shares. The Company can also cure this deficiency if the closing bid price of its common shares is $1.00 per share or higher for at least ten consecutive business days during the grace period, which includes the temporary COVID-19 relief period. In the event the Company does not regain compliance within the grace period and meets all other listing standards and requirements, the Company may be eligible for an additional 180-day grace period. During this time, the Company’s common shares will continue to be listed and trade on the Nasdaq.


About Castor Maritime Inc.

Castor Maritime Inc. is an international provider of shipping transportation services through its ownership of dry bulk vessels. The Company’s vessels are employed primarily on medium-term charters and transport a range of dry bulk cargoes, including such commodities as coal, grain and other materials along worldwide shipping routes.

The Company’s fleet currently consists of six Panamax dry bulk vessels.

For more information please visit the Company’s website at www.castormaritime.com


Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “plan,” “potential,” “will,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. In addition to these important factors, other important factors that, in the Company’s view, could cause actual results to differ materially from those discussed in the forward‐looking statements include general dry bulk shipping market conditions, including fluctuations in charterhire rates and vessel values, the strength of world economies the stability of Europe and the Euro, fluctuations in interest rates and foreign exchange rates, changes in demand in the dry bulk shipping industry, including the market for our vessels, changes in our operating expenses, including bunker prices, dry docking and insurance costs, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, the length and severity of the COVID-19 outbreak, the impact of public health threats and outbreaks of other highly communicable diseases, the impact of the expected discontinuance of LIBOR after 2021 on interest rates of our debt that reference LIBOR, the availability of financing and refinancing and grow our business, vessel breakdowns and instances of off‐hire, potential exposure or loss from investment in derivative instruments, potential conflicts of interest involving our Chief Executive Officer, his family and other members of our senior management, and our ability to complete acquisition transactions as planned. Please see our filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any forward‐looking statements as a result of developments occurring after the date of this communication.

CONTACT DETAILS
For further information please contact:

Petros Panagiotidis
Castor Maritime Inc.
Email: [email protected]

Media Contact:
Kevin Karlis
Capital Link
Email: [email protected]



FAIR Canada announces new funding and the election of its Board of Directors

TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) — FAIR Canada | Canadian Foundation for Advancement of Investor Rights is pleased to announce it has entered into an agreement with the Ontario Securities Commission (OSC) that will provide FAIR Canada with stable funding for the next five years. The OSC will provide a total of $3.75 million over the term agreement.

Jean-Paul Bureaud, the newly appointed Executive Director of FAIR Canada, said, “We are very appreciative of the new funding arrangement, which will bring stability andallow FAIR Canada tofocus on its mission of enhancing the rights of Canadian investors and being a national voice in securities regulatory development. The funding enables usto move our strategic priorities forward,including putting renewed focus onpolicy research. Importantly, it will also permit us to recruit additional staff to advance our core objectives.

FAIR Canada is also pleased to announce the election of the Board of Directors at the annual meeting of members held on November 9, 2020, the selection of Ellen Roseman to serve as its Chair, and Preet Banerjee as Vice-Chair of the Board. We also welcome the appointment of a new Director, Neil Gross. Mr. Gross is an experienced securities lawyer and former Executive Director of FAIR Canada. He is currently also Chair of the Investor Advisory Panel to the Ontario Securities Commission.

“Neil’s experience at FAIR Canada and as Chair of the Investor Advisory Panel, as well as his extensive experience as a securities lawyer, will be invaluable to FAIR Canada as we execute our strategic priorities. On behalf of the Board of Directors, we welcome Neil back to FAIR Canada in his new role
and look forward to his contribution,” said Ellen Roseman.

FAIR Canada’s Board of Directors is composed of the following individuals:

Preet Banerjee, Vice-Chair | Toronto
Larry Bates | Toronto
Lines Deslandes | Washington D.C.
Robb Engen | Calgary
Guy Lemoine | Montreal
Wanda Morris | Vancouver
Rossa O’Reilly | Toronto
Ellen Roseman, Chair | Toronto
Marc Ryan | Montreal

About FAIR Canada: FAIR Canada is a national, independent charitable organization dedicated to being a catalyst for the advancement of the rights of investors and financial consumers in Canada. As the voice of the Canadian investor and financial consumer, FAIR Canada advances its mission through outreach and education, public policy submissions to governments and regulators, proactive identification of emerging issues and other initiatives. FAIR Canada has a reputation for independence, thought leadership in public policy and moving the needle in the interests of retail investors and financial consumers.

For Further Information Contact:
FAIR Canada
[email protected]

Jean-Paul Bureaud
Executive Director, FAIR Canada
[email protected]